Department of Pediatrics, Wakayama Medical University, Wakayama, Japan.
Nephrol Dial Transplant. 2012 Aug;27(8):3186-90. doi: 10.1093/ndt/gfr750. Epub 2012 Jan 9.
The criterion of a renal biopsy in children with asymptomatic persistent isolated proteinuria is controversial.
To determine an adequate renal biopsy criterion in children with asymptomatic constant isolated proteinuria, the optimal cutoff maximum urinary protein/creatinine ratio (uP/Cr) to separate minor glomerular abnormalities (MGA) and other significant glomerular changes was obtained by receiver operating characteristic analysis in 44 children with asymptomatic constant isolated proteinuria (uP/Cr ≥ 0.2 g/g) screened from 1167 patients who underwent a renal biopsy between September 2000 and April 2010. Patients were divided into two groups according to the cutoff value to verify its validity.
The optimal uP/Cr was 0.5 g/g. In Group 1 (uP/Cr <0.5 g/g, n = 15), only one patient (6.7%) showed focal segmental glomerulosclerosis (FSGS) and the other 14 patients (93.3%) had MGA. In Group 2 (uP/Cr ≥ 0.5 g/g at least once before biopsy, n = 29), 5 patients showed FSGS and 7 patients had nephritis such as IgA nephropathy (41.4%, n = 12) and the other 17 patients (58.6%) showed MGA. These findings indicated that the ratio of non-MGA/MGA was significantly higher in Group 2 than that in Group 1 (P = 0.016) and that if renal biopsies were performed with a criterion of a maximum uP/Cr ≥ 0.5 g/g (criterion for Group 2), renal biopsies could be avoided in 45.2% of patients with MGA. One patient with FSGS in Group 1 showed proteinuria with uP/Cr ≥ 0.5 g/g in the clinical course.
An adequate renal biopsy criterion in children with asymptomatic constant isolated proteinuria is uP/Cr ≥ 0.5 g/g.
在无症状持续性孤立性蛋白尿患儿中,肾活检的标准存在争议。
为了确定无症状持续性孤立性蛋白尿患儿中合适的肾活检标准,通过对 2000 年 9 月至 2010 年 4 月间接受肾活检的 1167 例患者中筛选出的 44 例无症状持续性孤立性蛋白尿(uP/Cr≥0.2 g/g)患儿的最大尿蛋白/肌酐比值(uP/Cr)进行受试者工作特征分析,获得区分轻度肾小球异常(MGA)和其他显著肾小球改变的最佳 uP/Cr 截断值。根据该截断值将患者分为两组,以验证其有效性。
最佳 uP/Cr 为 0.5 g/g。在组 1(uP/Cr<0.5 g/g,n=15)中,仅有 1 例(6.7%)患者表现为局灶节段性肾小球硬化(FSGS),其余 14 例(93.3%)患者为 MGA。在组 2(至少在活检前一次 uP/Cr≥0.5 g/g,n=29)中,5 例患者表现为 FSGS,7 例患者表现为 IgA 肾病等肾炎(41.4%,n=12),其余 17 例(58.6%)患者表现为 MGA。这些结果表明,组 2 中非-MGA/MGA 的比例显著高于组 1(P=0.016),如果采用 uP/Cr≥0.5 g/g 的最大 uP/Cr 作为肾活检标准(组 2 标准),则可以避免 45.2%的 MGA 患者进行肾活检。组 1 中 1 例 FSGS 患者在病程中出现 uP/Cr≥0.5 g/g 的蛋白尿。
无症状持续性孤立性蛋白尿患儿合适的肾活检标准为 uP/Cr≥0.5 g/g。